Concussion

PreveCeutical Announces Closing of BioGene Therapeutics TransactionPreveCeutical Announces Closing of BioGene Therapeutics Transaction

PreveCeutical Announces Closing of BioGene Therapeutics Transaction

Vancouver, British Columbia--(Newsfile Corp. - November 15, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or…

7 months ago
Unify.Health Partners with CFLPA to Revolutionize Athlete Health Management and SafetyUnify.Health Partners with CFLPA to Revolutionize Athlete Health Management and Safety

Unify.Health Partners with CFLPA to Revolutionize Athlete Health Management and Safety

Athlete-controlled platform solves persistent problems around transparent, portable and accessible health data VANCOUVER, BC, Nov. 14, 2024 /CNW/ - Unify.Health, which…

7 months ago
Aviv Clinics Unveils Compelling Results on Treatment for Veterans Suffering from Post-Traumatic Stress DisorderAviv Clinics Unveils Compelling Results on Treatment for Veterans Suffering from Post-Traumatic Stress Disorder

Aviv Clinics Unveils Compelling Results on Treatment for Veterans Suffering from Post-Traumatic Stress Disorder

Novel Hyperbaric Oxygen Therapy Shows Promise in Treating Combat-Related PTSD in Veterans, lessening symptoms with lifechanging outcomesORLANDO, Fla., Nov. 13,…

7 months ago
PreveCeutical’s Subsidiary, BioGene Therapeutics, Appoints PresidentPreveCeutical’s Subsidiary, BioGene Therapeutics, Appoints President

PreveCeutical’s Subsidiary, BioGene Therapeutics, Appoints President

Vancouver, British Columbia--(Newsfile Corp. - November 13, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the…

7 months ago
ZetrOZ Systems Announces Winners of $20,000 STEM Scholarship & GrantZetrOZ Systems Announces Winners of $20,000 STEM Scholarship & Grant

ZetrOZ Systems Announces Winners of $20,000 STEM Scholarship & Grant

Innovation grants from the biotechnology creators of sustained acoustic medicine (sam®) will advance recipients' careers in biomedical engineering and sports…

7 months ago
PreveCeutical Launches Strategic Partnership with BioGene TherapeuticsPreveCeutical Launches Strategic Partnership with BioGene Therapeutics

PreveCeutical Launches Strategic Partnership with BioGene Therapeutics

Vancouver, British Columbia--(Newsfile Corp. - October 30, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the…

7 months ago
Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

TORONTO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”)…

7 months ago
PreveCeutical Engages Phoenix Corporate Finance Inc. to Provide Advisory ServicesPreveCeutical Engages Phoenix Corporate Finance Inc. to Provide Advisory Services

PreveCeutical Engages Phoenix Corporate Finance Inc. to Provide Advisory Services

Vancouver, British Columbia--(Newsfile Corp. - October 18, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or…

8 months ago
Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas SummitOragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit

Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit

SARASOTA, Fla., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Oragenics Inc. (NYSE American: OGEN), a company focused on developing new treatments…

8 months ago
Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial PreparationOragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation

Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation

SARASOTA, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biopharmaceutical company committed to developing novel…

8 months ago